Costs of long-course palliative radiotherapy acceptable in late-stage l...( A longer less intense course of radio...)

Costs of long-course palliative radiotherapy acceptable in late-stage lung cancer

A longer, less intense course of radiotherapy provides better value for the money than a shorter, more intense regimen when given to ease pain and other complaints in patients with late-stage nonsmall-cell lung cancer (NSCLC), according to a study in the December 20 issue of the Journal of the National Cancer Institute.

Patients with late-stage NSCLC are often too ill to receive intensive treatment for their cancer. Palliative radiotherapy is given to ease symptoms such as chest pain and difficulty breathing and swallowing. In 1999, Wilbert B. van den Hout, Ph.D., of Leiden University Medical Center in the Netherlands, and colleagues conducted a randomized clinical trial in 297 patients with inoperable stage IIIA/B or stage IV NSCLC to compare two palliative radiotherapy regimensa short course, two treatments of 8 gray (Gy) of radiation each, with a long course, 10 treatments of 3 Gy each. They found that the long course better eased symptoms over time and improved 1-year survival compared with the short course.

However, that study did not take into account the higher costs of the longer treatment and the continued medical costs of the patients who survive longer with their cancer. For this new study, van den Hout and colleagues conducted a costutility analysis of the two treatments to see which offers the best value for the money. Using data from a patient questionnaire on factors such as their mobility, ability to perform usual activities, and pain and anxiety levels, the authors calculated that quality of life was roughly equal in both treatment groups. However, because life expectancy was longer in the long-course treatment group, that groups overall quality-of-life benefit was greater than that in the short-course group.

The researchers also estimated the costs associated with the treatment and other nontreatment costs, such as medical care for people who survived their cancer. They estimated that the lifetime societal c
'"/>

Contact: Andrea Widener
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
19-Dec-2006

Page: 1 2
Related medicine news :

1. Costs of treating arthritis on the rise nationwide, study finds
2. Conference Costs/Benefits of HIV/AIDS Interventions Developing Countries
3. Costs of polypill could drain global health budgets
4. Costs of coronary artery bypass graft surgery
5. Costs of medical institutional review boards greater than previously estimated
6. $1.5 million awarded for palliative care research
7. Hospital palliative care programs continue rapid growth
8. New study shows palliative care programs surging trend in US hospitals
9. Should doctors consider male marital status when planning palliative treatment for bone metastasis?
10. Surgeons lack training in palliative surgical options
11. Breast cancer survivors experience long-term heart disease risk from radiotherapy

Post Your Comments: